Cynthia Smith
Independent DirectorMs. Cynthia Smith, MS, MBA, serves as Independent Director of Protara Therapeutics, Inc., January 29, 2021. She has been a Director of Tvardi Therapeutics, Inc. She serves as Independent Director of Agios Pharmaceuticals, Inc. since August 2022. She has been an Independent Director of Spero Therapeutics, Inc. since March 19, 2019. Ms. Smith serves as an Independent Director of Akebia Therapeutics, Inc. since August 28, 2018. She serves as on the Board of French-American Foundation. Ms. Smith served as Director at Dicerna Pharmaceuticals, Inc. since August 16, 2018 until 2021. She served as the Chief Commercial Officer of ZS Pharma, Inc. since June 2013 until January 3, 2017. Ms. Smith was responsible for marketing, sales, market access and other activities to support worldwide commercialization of the ZS Pharma's initial asset, ZS-9. She served as a Vice President of Market Access and Commercial Development at Affymax, Inc., since February 2, 2012 until March 2013. She served as an Executive Director of Public Policy, Payer Strategy and Operations at Affymax from 2008 to January 2012. From 2000 to 2008, Ms. Smith held various positions at Merck & Co., Inc., including Executive Director of Medicare and Healthcare Systems Strategy and was responsible for Medicare Part D customer strategy and for innovative healthcare delivery and contracting models for Merck’s chronic care product line. At Merck she served from June 2000 to October 2008 and held management positions in Public Policy and Government Affairs, including global crisis management for the Vioxx recall. Prior to joining Merck, she served as a senior analyst, healthcare policy for the White House Office of Management and Budget in the Clinton Administration from 1995 to 2000. She served as a Director of Nivalis Therapeutics, Inc. since November 1, 2016 until July 24, 2017. Ms. Smith holds an M.B.A. in Finance from the Wharton School of the University of Pennsylvania, an M.S. in Public Policy from the Eagleton Institute of Politics at Rutgers University and a B.A. in Communications from the University of North Carolina, Chapel Hill.
Positions
- Company NameProtara Therapeutics, Inc.Stock CodeTARAPositionIndependent DirectorColleagues
- JSJesse SheffermanCo-founder, CEO, President & Director
- LMLuke M. BesharIndependent Chairman of the Board
- JZJacqueline ZummoCo-Founder, Chief R&D Officer
- PFPatrick FabbioChief Financial Officer
- HFHannah FryVP, Principal Accounting Officer & Controller
- JOJustine O’MalleySenior Vice President of Investor Relations & Corporate Affairs
- GPGregory P. SargenIndependent Director
- RJRoger J. GarceauIndependent Director
- Company NameAgios Pharmaceuticals, Inc.Stock CodeAGIOPositionIndependent DirectorColleagues
- BMBrian M. GoffCEO & Director
- JAJacqualyn A. FouseChair of the Board of Directors
- CJCecilia JonesChief Financial Officer
- KVKrishnan ViswanadhanChief Strategy & Operations Officer
- JWJames William BurnsChief Legal Officer
- SGSarah GheuensChief Medical Officer and Head of Research & Development
- KIKaye I. Foster-CheekLead Independent Director
- CSCynthia SmithIndependent Director
- JDJeffrey D. CapelloIndependent Director
- Company NameSpero Therapeutics, Inc.Stock CodeSPROPositionIndependent DirectorColleagues
- EPEsther P. RajaveluCEO, President, CFO, Chief Business Officer, Treasurer & Director
- FEFrank Edward ThomasIndependent Chairman
- TKTimothy KeutzerChief Operating Officer
- JRJohn RaymondSenior Vice President of Finance & Business Operations
- DJDebra Jeske ZackChief Medical Officer
- ADAmy Dix RockChief Regulatory & Quality Officer
- CSCynthia SmithIndependent Director
- PGPaul G. AmbroseClinical Advisor
- GLGordon L. ArcherClinical Advisor
- Company NameAkebia Therapeutics, Inc.Stock CodeAKBAPositionIndependent DirectorColleagues
- JPJohn P. ButlerCEO, President & Director
- AAAdrian AdamsIndependent Chairperson
- EJErik John OstrowskiChief Business Officer, Senior VP, CFO & Treasurer
- SKSteven Keith BurkeSenior VP and Chief Research & Development Officer
- RCRichard C. MalabreSenior VP & Chief Accounting Officer
- JMJustin McCueSenior VP & Chief Technology Officer
- CSCynthia SmithIndependent Director
- MWMichael W. RogersIndependent Director
- RERonald E. FriesonIndependent Director
